calendar
125 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
next 91 dayslessmore
MonWedFri
125 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
AI grant. $209,758. PI: Paul K Drain
AT grant. $601,259. PI: Ashley E. Mason
NS grant. $568,920. PI: Theresa Currier Thomas
CA grant. $496,357. PI: DANIEL J BRAT
AT grant. $170,640. PI: Julia E. Hooker
AI grant. $210,302. PI: William Evan Johnson
DK grant. $231,000. PI: Roger D. Cone
NS grant. $230,562. PI: Thuy Nguyen
ES grant. $117,747. PI: Rebecca Sugrue
Therapy area: Gastrointestinal. Indication: Anal Fissure, Hemorrhoids
Therapy area: Dermatology. Indication: Vitiligo
Therapy area: Central Nervous System, Gastrointestinal. Indication: Inguinal Hernia, Post-Operative Pain
Therapy area: Immunology. Indication: Rheumatoid Arthritis
Therapy area: Immunology. Indication: Immunoglobulin G4-Related Disease (IgG4-RD)
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization, Dry (Atrophic) Macular Degeneration, Geographic Atrophy
Therapy area: Immunology. Indication: Rheumatoid Arthritis
Therapy area: Cardiovascular, Dermatology. Indication: Melasma (Chlosma), Venous Thromboembolism
Therapy area: Respiratory. Indication: Obstructive Sleep Apnea
Therapy area: Genito Urinary System, Non Malignant Disorders. Indication: Burning Sensation, Oral Submucosal Fibrosis
Therapy area: Oncology. Indication: Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Hypopharyngeal Cancer, Laryngeal Cancer, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Recurrent Head And Neck Squamous Cell Carcinoma
Therapy area: Oncology. Indication: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Therapy area: Respiratory. Indication: Seasonal Allergic Rhinitis
Therapy area: Ophthalmology. Indication: Open-Angle Glaucoma
Therapy area: Metabolic Disorders. Indication: Fabry Disease
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes